Company Ticker News March 8, 2022Ambrx Biopharma Inc. to Present at Oppenheimer's 32nd Annual Healthcare Conference 0 0 Share
Press Release February 15, 2022Ambrx Biopharma Inc. Announces Submission of IND Application for ARX305 with the U.S. FDA 0 0 Share
Company Ticker News December 29, 2021Ambrx Biopharma (AMAM) Sees Hammer Chart Pattern: Time to Buy? 0 0 Share
Press Release November 20, 2021Ambrx Biopharma Inc. Announces Acceptance of Two Poster Presentations at the 2021 San Antonio Breast Cancer Symposium 0 0 Share
Press Release November 4, 2021Ambrx Biopharma Inc. Announces First Patient Dosed in its Global Phase 2 ACE-Breast-03 Clinical Study of ARX788 for the Treatment of HER2-Positive Metastatic Breast Cancer 0 0 Share
Company Ticker News November 2, 2021Ambrx Biopharma Inc. to Present at the 30th Annual Virtual Credit Suisse Healthcare Conference 0 0 Share
Company Ticker News June 20, 2021Peter Thiel's Atai Life Sciences and 5 Other Companies List Shares 1 0 Share
